chrisvoncsefalvay/vaers-outcomes huggingface dataset:
first shot of Shingrix in September of 2018; tingling in her arms and legs; pain and tingling in her arms and legs / pain in her shin and thigh; fatigue; fever; redness and soreness at the injection site; soreness at the injection site; This case was reported by a consumer and described the occurrence of fever in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In September 2018, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, the patient received the 2nd dose of Shingrix. In September 2018, less than a day after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced fever, injection site erythema and injection site pain. On 7th January 2021, the patient experienced tingling of extremity, pain in extremity and fatigue. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the fever, injection site erythema and injection site pain were recovered/resolved and the outcome of the tingling of extremity, pain in extremity and fatigue were not recovered/not resolved and the outcome of the incomplete course of vaccination was unknown.   The reporter considered the fever, injection site erythema and injection site pain to be related to Shingrix. It was unknown if the reporter considered the tingling of extremity, pain in extremity and fatigue to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for the 2nd dose.   The patient received 1st dose of Shingrix in an unknown arm. Within 24 hours after receiving Shingrix, the patient had a fever.   She also had redness and soreness at the injection site that quickly cleared up.   A day after receiving the Shingrix, the patient began to experienced pain and tingling in her arms and legs.  She also had pain in her shin and thigh.  The patient reported that, this pain had gotten worse and that she experienced it off and on and that it got worse with exercise.  Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule. The reporter consented to follow up.
itching immediately after vaccines. reports 2 weeks of itching and scratching, petechaie developed over areas of itching. itching to bilateral arms, and right side of head. red skin to torso
My son was born with imperforate anus. I have had at least 18 vaccination shots against my will from 09-13.
Had petechiae of opposite arm 4 hours following COVID vaccination.  Petechiae took over a week to resolve.
Pt reports receiving seasonal influenza vaccine (received a facility, specific influenza vaccine type UNKNOWN, information not available; however, had to select one in order to submit report) four days prior to ED presentation today, 9 Nov 2022.  54yo F with hx of HTN, HLD, DMT2 who presents with L facial droop. Per patient, yesterday developed L shoulder pain radiating to L ear, awoke today with L facial weakness and droop including upper and lower L face (ie including forehead) with tearing of the L eye, decreased taste on the L anterior tongue.  Reports history of prior Bell's Palsy of unclear etiology but patient denies association with vaccination.  Neuro exam otherwise unremarkable, no loss of sensation. Normal TMs bilaterally. Vitals with HTN, otherwise normal.   No other illness symptoms, no hx of HSV infection or symptoms, no history concerning for exposure to lyme disease.  Treated with prednisone 60mg x7 days, eye drops, and erythromycin ointment for L eye at nighttime due to incomplete closure of eyelids. Discharged with instructions to follow-up with PCP.  Patient also reports getting a COVID booster within the last month, but could not specific the date, was prior to influenza vaccination; she does not have record of which COVID vaccination she received.
No reported side effects; Medical Assistant reported that an expired dose of MMR-II was administered to a patient. Caller was unable to provide sterile diluent information stating they do not have a way to document the lot and expiration for the diluent. Caller confirmed ther; This spontaneous report was received from a medical assistant and refers to a 12-month-old female. patient.  The patient's medical history, concurrent conditions and previous drugs reactions or allergies were not reported. Concomitant medications included sterile diluent (manufacturer unknown).  On 15-AUG-2022, the patient was vaccinated with an expired  measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) at a dose of 0.5ml subcutaneously,1 dose, lot #T029549, expiration date: 10-SEP-2022, for prophylaxis (vaccination scheme was not provided) (expired product administered). It was mentioned that no side effects occurred.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2209USA002251:02240957 US-009507513-2209USA002394:
Around 4am on the morning after I had the second dose of the Moderna vaccine, I experienced a Laryngospasm / throat closure. I was gasping for air and choking as I was trying to wake myself up, it took about 5 minutes for my throat to fully open back up.
No additional AEs; Nurse called in to report that on today 10May2023 while giving a 6 month old patient ROTATEQ, the child arched their back and some of the medication got in the child's eye.  No additional information was reported.  No Additional AEs, no PQCs.; Nurse called in to report that on today 10May2023 while giving a 6 month old patient ROTATEQ, the child arched their back and some of the medication got in the child's eye.  No additional information was reported.  No Additional AEs, no PQCs.; This spontaneous report was received from Other Health Professional and refers to a 6-month-old male.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 10-MAY-2023, the patient started therapy with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 1 time dose, lot #1925936, expiration date: 28-MAR-2024, administered orally for prophylaxis (strength was not provided).  On 10-MAY-2023, nurse called in to report that today, while giving a 6 month old patient rotavirus vaccine, live, oral, pentavalent (ROTATEQ), the child arched their back and some of the medication got in the child's eye (Inadvertent exposure to vaccine and Exposure via eye contact). No additional information was reported. No Additional AEs, no PQCs. No treatment was given for events.
It was reaction reported on a small percentage of people; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (It was reaction reported on a small percentage of people) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (It was reaction reported on a small percentage of people). At the time of the report, VACCINATION COMPLICATION (It was reaction reported on a small percentage of people) outcome was unknown.      No concomitant medications were reported.  No treatment information was provided.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 26-MAR-2015, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance and for the long-term prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On an unknown date in 2017, the patient was treated by a physician for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
About 6-7 hours after shot, I started feeling achy and feverish.  About 10 hours after the shot, I had uncontrollable shaking for about 2 hours.  I was so cold, I could warm up all night.  I had to clench my teeth to keep from biting my tongue.  I also felt nauseous all that night and the next day.  I couldn't lay flat that night or I felt like I would vomit.  Once the shaking subsided (after 3 Tylenol), I still couldn't sleep because of the nausea and the aching.  I got about 2 hours of sleep and woke in the morning with a massive headache.  I took more Tylenol and it helped with the headache but had chills and nausea all day.  I slept much of the afternoon and all that next night.  The following day, I still felt a bit nauseous, achy and fatigued but much better than prior.  By the following day, I was back to normal.
Pt recvd 3 doses of Engerix-B & JAN92 titer result was neg; scheduled to receive a booster dose the end of JAN92;
chills; fever; achy joints; muscle pain; This case was reported by a consumer via interactive digital media and described the occurrence of chills in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th August 2020, the patient received Shingrix. In August 2020, less than a week after receiving Shingrix, the patient experienced chills, fever, joint pain and muscle pain. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the chills, fever, joint pain and muscle pain were unknown.   It was unknown if the reporter considered the chills, fever, joint pain and muscle pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had chills, fever, achy joints, muscle pain. The patient took 500 mg Tylenol at 3 hrs ago.  The reporter asked what else he could did.
Information has been received from a physician concerning a patient who was vaccinated with a dose of ZOSTAVAX . Subsequently the patient had "low titers." No adverse reactions" were reported by the physician. Follow up information was received from the physician who indicated that he did not have any further information and he could not remember who called for a consult as he got 3-7 consults per day by the phone. Additional information is not expected.
15 post vaccine administration patient reported  feeling week and also having numbness in her legs as she tried to stand up to leave. Assessment performed and VS as follows at 0900: BP 114/63, HR 79, O2: 98% at 0905 BP 123/70, HR 88, O2: 99%. Pt observed for approximately 10 minutes and reported improvement in symptoms. Pt discharged home in stable condition accompanied by family member
COVID Vaccine Breakthrough Case. Moderna Dose 1 2/17/21 (031L20A). Moderna Dose 2 3/17/21 (036A21A). COVID Negative 9/18/21. COVID Positive 9/28/2021. 9/28/21: A 76-year-old man with a history of myelodysplastic syndrome, hypertension, anxiety, recent CVA in the right middle cerebral artery distribution, right internal carotid artery stenosis who was discharged from local Medical Center on 09/22/2021 where he was managed for an acute CVA. Patient was discharged to the rehab unit, prior to discharge, COVID-19 screen done on 09/18 2021 was negative. Today while at the rehab unit he develops a fever T-max of 102.1 degrees. He is 96% on room air. Sepsis workup done, chest x-ray reveals no infiltrate, the lungs are clear. Urinalysis not suggestive of UTI. Lactic acid was 1.2.  CBC done reveals pancytopenia with WBC of 2000, platelet count of 33000 hemoglobin of 12.3. COVID-19 screen done on 09/28/2021 is positive. Patient transferred to local Medical Center for further evaluation. At time of evaluation, patient denies cough, no headaches, no diarrhea, abdominal pain or vomiting. No dysuria. 10/7/21: Patient is a 76-year-old male initially admitted to the hospital for left hemiparesis evaluation noted for ischemic CVA involving the right middle cerebral artery distribution patient was subsequently sent to acute rehab for further care, his acute rehab course was cut short due to positive COVID test result without any symptoms patient was subsequently transferred back to local hospital for further care. During the course of this hospitalization, patient continue to work with therapy, did not requiring any supplemental oxygen and did not have any respiratory distress. Patient was noted to have right index finger paronychia for which he was started on p.o. Keflex. Patient will be discharged home with antibiotic for completion, referred to VNA for RN, PT and OT.  Recommended follow-up with PCP within 1 week.
Within the 24 hours after I experienced an intense tightening of my back between my shoulder blades and more to the right side.  It was  painful breathing in fully, taking a deep breath, lesser so when I breathe shallowly.  I felt very weak overall with multiple joints feeling pain (ankles, knees, wrist that was previously injured).  The intensity of the back/between shoulder blades pain remained throughout the following day and a bit lesser so into day three (now).
S uspected vaccination failure; I had the shots and still got shingles; pain was nothing compared to the pain from shingles; the pain in my shoulder and neck are still as painful as the first week; neck are still as painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included third degree burns (Last year patient had third degree burns on ankle) and pain.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: S uspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: I had the shots and still got shingles), pain (Verbatim: pain was nothing compared to the pain from shingles), shoulder pain (Verbatim: the pain in my shoulder and neck are still as painful as the first week) and neck pain (Verbatim: neck are still as painful). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not reported and the outcome of the shoulder pain and neck pain were not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain, shoulder pain and neck pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, pain, shoulder pain and neck pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 27-JUN-2023. This case was reported by a patient via interactive digital media. The patient said get your Shingles shot.  Shingles was something you did not want to get.  The shot did not always mean you would not get the shingles, patient had the shots and still got shingles, but why take a chance. Last year patient had third degree burns on his/her ankle, that pain was nothing compared to the pain from shingles. Six weeks and the pain in patient shoulder and neck were still as painful as the first week.Get the shot. This case was considered as suspected vaccination failure as detail regarding completion of primary vaccination schedule, laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Severe flu-like symptoms. Chills, fever, headach, body aches. Arm is red from vaccine site to almost elbow. Very sore arm.
"Moderna COVID-19 Vaccine EUA" -Received vaccine at 8:00am. Felt fine till approx. 3:30pm at which time started becoming feeling exhausted and yawning excessively. Began aching all over especially in areas of previous injuries. Took Tylenol 1gm for aches. 1 hour later shivers and checked temp that was 99.5 orally. At 8:00pm symptoms intensified along with lightheadedness and burning feeling throughout trunk/Chest. Started vomiting around 10:30pm. Vomited x2. Headache, shivers, aching, excessive yawning lasted till around 5:00am which at that point was able to keep Tylenol down. Symptoms from that point on subsided over time. Very tired and sore for the next 12 hours. Jaws sore from the excessive yawning remain.
Information has been received from a physician concerning a 25 year old female patient who on 30-AUG-2010 was vaccinated with the first dose of GARDASIL. Concomitant therapy included "LYSTDA". The physician reported that the patient was using GARDASIL and had muscle twitching, back problems and surgery. The outcome of the patient was not reported. The patient was sent to her family practice physician. Physician considered back problems, muscle twitching and surgery as other important medical events. Additional information has been requested.
This case was reported by a consumer and described the occurrence of pruritus in a 65-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included Influenza Vaccine (gets flu shots but had never experienced an effect like this before) and Niacin (experienced similar symptoms but this was not as extreme). Concomitant products included CRESTOR. On 4th June 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 4th June 2018, 1 hr after receiving SHINGRIX, the patient experienced pruritus, tingling sensation, shoulder pain and neck pain. On 5th June 2018, the patient experienced tiredness. On an unknown date, the outcome of the pruritus, tingling sensation, shoulder pain, neck pain and tiredness were recovering/resolving. The reporter considered the pruritus, tingling sensation, shoulder pain and neck pain to be probably related to SHINGRIX. The reporter considered the tiredness to be possibly related to SHINGRIX. Additional details were provided as follows: At 09:20 hours, the patient received SHINGRIX in the left arm. Shortly after vaccination (1 hour), the patient experienced tingly or itchy feeling in both arms, more noticeable in left arm which was arm of injection. Less than a day after vaccination, the patient experienced soreness in his shoulder and on the left side of his neck. The condition was improving on 5th June 2018. One day after vaccination, the patient experienced tiredness. The patient was asking if this was a possible side effect from SHINGRIX. The patient also asked to the pharmacist who gave injection and she did not know. The patient had placed her call to her physician and was still awaiting call back. The patient was not experiencing other symptoms. The patient stated the response was appreciated.
feeling really tired; This is a spontaneous report from a contactable consumer (patient) received via  Support. An 86-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: unspecified), via an unspecified route of administration on 09Feb2021 dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: unspecified), via an unspecified route of administration on an unspecified date dose 1, single for COVID-19 immunization. Patient reported that she received the second dose of the Covid vaccine on February 9th and was still feeling really tired (2021). Patient asked if that can still be a reaction from the vaccine, further stated that she had back aches and other problems and wasn't sure if her being this fatigued was still from the vaccine. Patient stated she had not gotten much exercise and it had her feeling sorry for herself. The clinical outcome for the event was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
she accidently hit the nurses arm and the medicine spilled out with no adverse event; Initial information received on 11-Nov-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 5 year old who accidently hit the nurses arm and the medicine spilled out, Caller states that she is unsure of how much of the vaccine the patient received. The  syringe had 0.3 or 0.4ml left in it with no adverse event ((underdose), while she received vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose  dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot C573AA via unknown route in unknown administration site.  On an unknown date (unknown latency) it was reported that patient accidently hit the nurses arm and the medicine spilled out, Caller states that she is unsure of how much of the vaccine the patient received. The  syringe had 0.3 or0.4ml left in it with no adverse event (underdose).  Other relevant tests included no lab data.  Final diagnosis was underdose.  An unknown corrective treatment was received.  There will be no information available on the batch number for this case
Painful injection site almost immediately. Extremely sore the next day. I didn't want to lift my arm. A pounding headache the next day. And my whole body hurt the next day.
At time of injection small red hard  in duration   8 days later developed at injection site 4 cm hard red area. Aching warm to touch. Sore. Was not like this until 8 days after shot
The evening of the shot, I started having chills and nasuea and threw up around midnight. The next day I was very tired and rested all day. By the 3rd day, I was feeling 90% improved and by day 4, I feel back to normal.
abrupt loss of smell and taste following second Moderna vaccine dose loss of smell and taste persists today
I have tinnitus...so loud I can not get away from it. I noticed it when I went to sleep last night. I had the shot at 3Pm Saturday. I woke up at 3:47 and started to feel terrible. Chills, severe congestion, head hurt so bad, nauseous, ached all over. I have never felt so badly EVER. at 3pm Sunday I took two tylenol and everything got better. I was fatigued but functioning. I still had a slight headache but was able to eat a light dinner. Monday I was so fatigued I could not drive or go to work. I had severe brain fog.  Monday night I noticed how loud my ears were when I went to bed. I could not get away from the noise. today the brain fog seems to be lifting but I am still drained and not feeling great. no energy. I have heart palpitations and shortness of breath. At one point I had a pain in my chest and was concerned about a blood clot. That seems to have passed the palpiations remain.